Are you Dr. Mangan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 103 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3401 N Broad St
Philadelphia, PA 19140Phone+1 215-707-4000Fax+1 215-707-5066
Summary
- Dr. Kenneth Mangan, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Temple University Hospital and Temple University Hospital - Jeanes Campus.
Education & Training
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1976 - 1979
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1975 - 1976
- George Washington UniversityResidency, Internal Medicine, 1973 - 1975
- George Washington University School of Medicine and Health SciencesClass of 1973
Certifications & Licensure
- PA State Medical License 1981 - 2014
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 1999
- Super Doctor SuperDoctors.com
Clinical Trials
- Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma Start of enrollment: 1993 Feb 01
- Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 1993 Feb 01
- Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer Start of enrollment: 1996 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsDonor Lymphocyte Infusion in Hematologic Malignancies—Good to be Fresh?Nasheed Hossain, Thomas R. Klumpp, John Ulicny, Michael Garner, Patricia Kropf
Clinical Lymphoma, Myeloma & Leukemia. 2016-02-01 - 14 citationsT-cell chronic lymphocytic leukaemia: anomalous cell markers, variable morphology, and marked responsiveness to pentostatin (2'-deoxycoformycin).A. S. D. Spiers, M. P. Davis, Marilyn Levine, C. Y. Li, Kenneth F. Mangan
Scandinavian Journal of Haematology. 2009-04-24 - 79 citationsA Randomized Phase 3 Study of Peripheral Blood Progenitor Cell Mobilization With Stem Cell Factor and Filgrastim in High-Risk Breast Cancer PatientsElizabeth J. Shpall, Catherine Wheeler, Stewart A. Turner, Saul Yanovich, Randy A. Brown
Blood. 1999-04-15
Grant Support
- Cellular Interactions In Human HematopoiesisNational Institute Of Allergy And Infectious Diseases1987–1989
- Cellular Interactions In Human HematopoiesisNational Institute Of Allergy And Infectious Diseases1987
Professional Memberships
- Member
- Fellow